99 related articles for article (PubMed ID: 17055459)
41. The ins and outs of adrenergic signaling.
Lohse MJ
J Mol Med (Berl); 2015 Sep; 93(9):955-62. PubMed ID: 26199112
[TBL] [Abstract][Full Text] [Related]
42. [Molecular mechanisms of apoptosis pathology].
Belushkina NN; Severin SE
Arkh Patol; 2001; 63(1):51-60. PubMed ID: 11242859
[TBL] [Abstract][Full Text] [Related]
43. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.
Ou X; Tan Y; Xie J; Yuan J; Deng X; Shao R; Song C; Cao X; Xie X; He R; Li Y; Tang H
Drug Resist Updat; 2024 Mar; 73():101063. PubMed ID: 38335844
[TBL] [Abstract][Full Text] [Related]
44. Influence of
Li Y; Cui WW; Yang ZF; Liu WH; Bian MW; Deng J; Wang T
Chin Med Sci J; 2024 Mar; 39(1):9-18. PubMed ID: 38426412
[TBL] [Abstract][Full Text] [Related]
45. Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5A.
Zhao X; Stein KR; Chen V; Griffin ME; Lairson LL; Hang HC
Nat Chem Biol; 2023 Oct; 19(10):1205-1214. PubMed ID: 37248411
[TBL] [Abstract][Full Text] [Related]
46. GPRC5A: A potential tumor suppressor and oncogene.
Acquafreda T; Soprano KJ; Soprano DR
Cancer Biol Ther; 2009 May; 8(10):963-5. PubMed ID: 19593893
[No Abstract] [Full Text] [Related]
47. Subcellular Organization of the cAMP Signaling Pathway.
Zaccolo M; Zerio A; Lobo MJ
Pharmacol Rev; 2021 Jan; 73(1):278-309. PubMed ID: 33334857
[TBL] [Abstract][Full Text] [Related]
48. 2011: Signaling breakthroughs of the year.
Adler EM
Sci Signal; 2012 Jan; 5(205):eg1. PubMed ID: 22215729
[TBL] [Abstract][Full Text] [Related]
49. A novel signaling mechanism in brain development.
Piao X; Walsh CA
Pediatr Res; 2004 Sep; 56(3):309-10. PubMed ID: 15269343
[No Abstract] [Full Text] [Related]
50. Microbiota metabolites as agonists for the orphan receptor GPRC5A.
Nat Chem Biol; 2023 Oct; 19(10):1183-1184. PubMed ID: 37248414
[No Abstract] [Full Text] [Related]
51. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
[TBL] [Abstract][Full Text] [Related]
52. The emerging roles of GPRC5A in diseases.
Zhou H; Rigoutsos I
Oncoscience; 2014; 1(12):765-76. PubMed ID: 25621293
[TBL] [Abstract][Full Text] [Related]
53. Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor.
Cheng Y; Lotan R
J Biol Chem; 1998 Dec; 273(52):35008-15. PubMed ID: 9857033
[TBL] [Abstract][Full Text] [Related]
54. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms underlying the induction of the putative human tumor suppressor GPRC5A by retinoic acid.
Ye X; Tao Q; Wang Y; Cheng Y; Lotan R
Cancer Biol Ther; 2009 May; 8(10):951-62. PubMed ID: 19279407
[TBL] [Abstract][Full Text] [Related]
56. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
[TBL] [Abstract][Full Text] [Related]
57. An In Silico Analysis Reveals Sustained Upregulation of Neuroprotective Genes in the Post-Stroke Human Brain.
Betto F; Chiricosta L; Mazzon E
Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508918
[TBL] [Abstract][Full Text] [Related]
58. Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity.
Long E; Yin J; Funderburk KM; Xu M; Feng J; Kane A; Zhang T; Myers T; Golden A; Thakur R; Kong H; Jessop L; Kim EY; Jones K; Chari R; Machiela MJ; Yu K; ; Iles MM; Landi MT; Law MH; Chanock SJ; Brown KM; Choi J
Am J Hum Genet; 2022 Dec; 109(12):2210-2229. PubMed ID: 36423637
[TBL] [Abstract][Full Text] [Related]
59. GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis.
Qian X; Jiang C; Shen S; Zou X
J Cancer; 2021; 12(7):2010-2022. PubMed ID: 33753999
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
